Riskpilot← Back to searchSign inGet full accessVezer Oy
OYActiveY-tunnus 3195084-2Niiralankatu 19Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20217 employees
Revenue 2025
EUR 1,6M
+17% vs 2024
EBITDA margin
4.6%
+140% vs 2024
Equity ratio
-84.9%
Financial strength
Net profit 2025
EUR -18K
+92% vs 2024
| Revenue | EUR 1,6M | +17% |
| EBITDA | EUR 72K | +140% |
| Net profit | EUR -18K | +92% |
| Total assets | EUR 341K | +29% |
| Equity | EUR -290K | +22% |
| Employees | 7 | — |
Legal name
Vezer Oy
Y-tunnus number
3195084-2
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3. maaliskuuta 2021
Share capital
EUR 0
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Lääketukkukauppa, tukkukauppa, Laboratorio- ja sairaanhoitovälineiden tukkukauppa, kaikki laillinen liiketoiminta.
Address
Niiralankatu 19
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 1 261 | 1 228 | 1 346 | 1 572 |
| Staff expenses | −256 | −218 | −353 | −367 |
| EBITDA | −74 | −7 | −182 | 72 |
| Depreciation & amort. | −6 | −9 | −13 | −24 |
| EBIT | −80 | −16 | −194 | 49 |
| Net financials | −16 | −21 | −43 | −67 |
| Profit before tax | −96 | −38 | −238 | −18 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −96 | −38 | −238 | −18 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 230 | 42 042 | 265 | 341 |
| Equity | −96 | −134 | −371 | −290 |
| Long-term debt | 124 | 28 832 | 304 | 283 |
| Short-term debt | 202 | 26 574 | 332 | 348 |
| Total debt | 326 | 55 406 | 636 | 630 |
EBITDA margin
4.6%
This company
15.8%
Market median
-71% vs market
20222025
Equity ratio
-84.9%
This company
38.2%
Market median
-322% vs market
20222025
Return on equity
-1815600.0%
This company
18.4%
Market median
-9867491% vs market
20222025
Net profit margin
-1.2%
This company
8.1%
Market median
-115% vs market
20222025
Asset turnover
4.61×
This company
1.12×
Market median
+312% vs market
20222025
Debt / equity
2.18×
This company
0.62×
Market median
-252% vs market
20222025
- Annual report 2025Filed via PRH / YTJ · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-09-01 – 2023-06-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-03-03 – 2022-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MJ Chief Executive Officer | Chief Executive Officer | 2021 |
JH Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vezer Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Markus Juhani Piippo | Chief Executive Officer | 0 companies |
| Juha Heikki Jestola | Deputy Chief Executive Officer | 0 companies |
| Sami Miikael Piippo | Board of Directors | 0 companies |
| Ilkka Juhani Lakovaara | Board of Directors | 0 companies |
| Juha Erkki Antero Rautio | Board of Directors | 0 companies |